#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Systemic sclerosis pulmonary Non-small cell lung cancer metastatic Bile acid synthesis disorder Prodromal Alzheimer's disease Ehlers-Danlos syndrome Progressive familial intrahepatic cholestasis Plasma cell myeloma Homocystinuria Frostbite Myasthenia gravis Hereditary motor and sensory neuropathy Ewing's sarcoma recurrent Primary biliary cholangitis Fibrosarcoma metastatic Neuroendocrine tumour of the lung More trials…

    Learn about Rare Diseases

    Osteosarcoma – Treatment Ehlers-Danlos syndrome – Basic Information Antithrombin III deficiency Nodal marginal zone B-cell lymphoma – Diagnostics Erdheim-Chester disease – Treatment Waldenstrom’s macroglobulinaemia recurrent – Basic Information Synovial sarcoma metastatic – Basic Information Haemophagocytic lymphohistiocytosis – Trials in Disease Leiomyosarcoma – Basic Information Encephalitis autoimmune – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amlitelimab Treg02 Mercaptopurine Pehero Micafungin Hhalpc SECRETIN SYNTHETIC HUMAN Mirikizumab Zidovudine Milnacipran Hydrochloride GSKVX000000017986 Alectinib Hydrochloride Ioversol Db-1303 Osilodrostat Mitomycin ULTEVURSEN Dolutegravir Sodium Sodium S-Lactate Solution Choriogonadotropin Alfa More therapies…

    Learn about Your Condition

    Metastatic glioma Pericarditis Exudative retinopathy Laryngeal cancer stage I Osteosarcoma recurrent Oesophageal cancer metastatic Thermal burn Adrenogenital syndrome Choroidal neovascularisation Mumps Small intestine leiomyosarcoma Neurogenic bladder Demyelination Synovial sarcoma metastatic Lichen planus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on TAK-861 for Treating Narcolepsy with Cataplexy in Patients

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Narcolepsy
    Investigated Drugs:
    • N-{(2S,3R)-4,4-Difluoro-1-(2-Hydroxy-2-Methylpropanoyl)-2-[(2,3′,5′-Trifluoro[1,1′-Biphenyl]-3-Yl)Methyl]Pyrrolidin-3-Yl}Ethanesulfonamide
    Austria Belgium Czechia Denmark Finland France +5

  • Study on Ketamine for Treating Patients with Severe Brain Injury and Disorders of Consciousness

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Brain injury
    Investigated Drugs:
    • Ketamine
    • Sodium Chloride
    Belgium

  • Study on Reducing Inflammation in Acute Ischemic Stroke Patients Using Dornase Alfa and Sodium Chloride

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Dornase Alfa
    • Sodium Chloride
    Germany

  • Study on the Effects of Botulinum Toxin A for Improving Arm Function in Patients with Chronic Stroke

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Cerebrovascular accident
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    France

  • Study on the Effects of Semaglutide and Dulaglutide in Adults with Multiple Sclerosis Aged 18-60 with High Disease Activity

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Dulaglutide
    • Semaglutide
    Slovakia

  • Study on the Effect of Pregabalin on Sleep and Pain in Patients with Neuropathic Pain

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Neuralgia
    Investigated Drugs:
    • Pregabalin
    Finland
Previous Page
1 … 75 76 77 78 79 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!